olanzapine


Also found in: Medical, Wikipedia.

o·lan·za·pine

 (ə-lăn′zə-pēn′)
n.
A psychotropic drug, C17H20N4S, used to treat schizophrenia, bipolar disorder, and acute psychosis.

[olan-, origin unknown + alteration of (dia)zepine, seven-member ring containing two nitrogens; see benzodiazepine.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

olanzapine

n olanzapina
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Alkermes provided an update on its regulatory strategy for ALKS 3831, the company's investigational, novel, once-daily, oral atypical antipsychotic drug candidate designed to provide the efficacy of olanzapine while mitigating olanzapine-associated weight gain.
Olanzapine is a widely prescribed potent antipsychotic drug with approved efficiency for the treatment of schizophrenia and bipolar disorder.
Objective: To compare frequency of Hyperprolactinemia with Risperidone and Olanzapine in patients with first episode psychosis.
- The first subject has been dosed in a Phase 1, randomized, double-blind, placebo-and-active controlled crossover study of Seattle-based, privately-held biopharmaceutical company Impel NeuroPharma's intranasal olanzapine product, INP105, dosed via Impel's proprietary Precision Olfactory Delivery, or POD, intranasal delivery device, the company said.
THURSDAY, June 14, 2018 (HealthDay News) -- Youth receiving antipsychotic treatment have adverse changes in adiposity and insulin sensitivity, with the greatest fat increases seen with olanzapine, according to a study published online June 13 in JAMA Psychiatry.
Market approval of olanzapine was issued by both the American Food and Drug Administration (FDA) and the European Medicines Agency (EMA) in 1996.
Of the atypical antipsychotics, olanzapine holds the promise of the most favorable effects on sleep.
We present the case of a 27-year-old man with a history of paranoid schizophrenia that showed signs consistent with NMS that occurred after treatment with olanzapine. The patient was adherent to treatment.
Unlike clozapine, and despite its structural similarities, olanzapine is not usually associated with haematological suppression.
Olanzapine has been reported to induce priapism in several adult cases with schizophrenia and/or mood disorders but very rarely reported in children.
Here, we present the first case report of successful treatment with olanzapine monotherapy for mania after a traumatic brain injury.